Protillion Biosciences Raises $18 Million Sequence A Financing Led by ARCH Enterprise Companions and Illumina Ventures
Protillion’s transformational drug discovery and optimization platform generates exact protein information with the dimensions to bridge superior computation and real-world outcomes Platform can establish and optimize new protein therapeutics to speed up R&D productiveness BURLINGAME, Calif., Dec. 19, 2022 /PRNewswire/ — Protillion Biosciences, a privately held biotech firm working to establish and optimize new protein […]
Continue Reading